These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3770056)

  • 21. Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.
    Bolanowska W; Gessner T
    Xenobiotica; 1982 Feb; 12(2):125-36. PubMed ID: 7090422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time dependency of adriamycin and adriamycinol kinetics.
    Gil P; Favre R; Durand A; Iliadis A; Cano JP; Carcassonne Y
    Cancer Chemother Pharmacol; 1983; 10(2):120-4. PubMed ID: 6831625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Pierce RN; Jatlow PI
    J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative uptake and retention of adriamycin and N-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures.
    Israel M; Sweatman TW; Seshadri R; Koseki Y
    Cancer Chemother Pharmacol; 1989; 25(3):177-83. PubMed ID: 2598408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid distribution of adriamycin in the ascitic and pleural fluid of women with ovarian carcinomas.
    Lazo JS; Schwartz PE
    Gynecol Oncol; 1985 May; 21(1):65-72. PubMed ID: 3988127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic metabolism of doxorubicin in mice and rats.
    Vrignaud P; Londos-Gagliardi D; Robert J
    Eur J Drug Metab Pharmacokinet; 1986; 11(2):101-5. PubMed ID: 3770010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Might adriamycinol contribute to adriamycin-induced cardiotoxicity?
    Del Tacca M; Danesi R; Ducci M; Bernardini C; Romanini A
    Pharmacol Res Commun; 1985 Nov; 17(11):1073-84. PubMed ID: 4089011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography.
    Shinozawa S; Mimaki Y; Araki Y; Oda T
    J Chromatogr; 1980 Aug; 196(3):463-9. PubMed ID: 7430305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enzymology of doxorubicin quinone reduction in tumour tissue.
    Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
    Eksborg S; Stendahl U; Lönroth U
    Eur J Clin Pharmacol; 1986; 30(5):629-31. PubMed ID: 3463510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.
    Brenner DE; Galloway S; Cooper J; Noone R; Hande KR
    Cancer Chemother Pharmacol; 1985; 14(2):139-45. PubMed ID: 3971478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients.
    Cummings J; Forrest GJ; Cunningham D; Gilchrist NL; Soukop M
    Cancer Chemother Pharmacol; 1986; 17(1):80-4. PubMed ID: 3698181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative determination of adriamycin in rat hepatocytes using a volatile extraction buffer, HPLC and fluorescence detection.
    Mahdadi R; Pommery N; Pommery J; Lhermitte M
    Biomed Chromatogr; 1987; 2(3):91-4. PubMed ID: 3507221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.
    Hartman N; Basseches PJ; Powis G
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):11-5. PubMed ID: 6819097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.
    Terasaki T; Iga T; Sugiyama Y; Sawada Y; Hanano M
    J Pharmacobiodyn; 1984 May; 7(5):269-77. PubMed ID: 6470925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of adriamycin and adriamycinol in micro volumes of rat plasma.
    Bots AM; Van Oort WJ; Noordhoek J; Van Dijk A; Klein SW; Van Hoesel QG
    J Chromatogr; 1983 Feb; 272(2):421-7. PubMed ID: 6833441
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.
    Eksborg S; Cedermark BJ; Strandler HS
    Med Oncol Tumor Pharmacother; 1985; 2(1):47-54. PubMed ID: 4058077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.